Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Longhui Biological Pharmaceutical is a Chinese biotechnology company dedicated to the research, development, and production of veterinary biological products. Headquartered in the Yangling Agricultural High-tech Industries Demonstration Zone, the company primarily serves the livestock industry with a focus on swine health. Its commercial portfolio features essential vaccines, including those for Classical Swine Fever and Porcine Reproductive and Respiratory Syndrome (PRRS). Shaanxi Longhui operates state-of-the-art GMP-certified manufacturing facilities and leverages collaborations with academic institutions to drive innovation in animal vaccines. The company plays a significant role in the regional agricultural technology ecosystem in Shaanxi Province.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shaanxi Longhui Biological Pharmaceutical.